Priscila Vernizi Roth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Priscila Vernizi Roth has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Vânia Oliveira Carvalho
Pediatric Dermatology Division, Department of Pediatrics, Federal University of Paraná, UFPR, Curitiba, Brazil
4 shared publications - Mariana Aparecida Pasa Morgan
Faculdade Ceres
3 shared publications - Ana Chrystina de Souza Crippa
Universidade Federal do Paraná, Hospital das Clínicas, Unidade de Neuropediatria, Curitiba PR, Brazil
2 shared publications - Rafaela Cachiolo Antunes
Federal University of Parana, Curitiba, Brazil
2 shared publications - Renata Drizlionoks
Federal University of Parana, Curitiba, Brazil
2 shared publications Bianca Manfroi da Silva
1 shared publication
Latest Publications
- 28 November 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (6) , 1225-1230
Development of the AAcQLI : A New Instrument for Assessing Quality of Life in Children With Alopecia Areata
Background: Alopecia areata (AA) is a chronic inflammatory disease characterized by non‐scarring hair loss, which can markedly affect the quality of life (QoL) of children. The absence of disease‐specific instruments to measure this impact motivated the development of the Alopecia Areata Children's Quality of Life Index (AAcQLI). Methods: This study aims to develop and validate a disease‐specific instrument to assess QoL in children with AA, addressing emotional, social, and functional domains. The AAcQLI was developed through a review of existing instruments, refined by an expert committee, and tested in a pilot sample. Its psychometric properties were evaluated by examining content and construct validity, while reliability was assessed through test–retest and internal consistency using Cronbach's α coefficient. Results: The study sample comprised 20 children, with a median age of 9.5 years (interquartile range [IQR] = 7.5–13). The AAcQLI demonstrated good internal consistency (Cronbach's α = 0.86) and excellent content validity (Content Validity Index = 1.0). Convergent validity indicated fair agreement with the Children's Dermatology Life Quality Index (CDLQI) ( k = 0.24) and slight agreement, as measured by the Severity of Alopecia (SALT) ( k = 0.08). Conclusion: The AAcQLI is a promising tool for assessing quality of life in children with AA. Further studies with larger and more diverse populations are warranted to refine its measurement properties and strengthen its clinical applicability in evaluating the psychosocial impact of the disease.
- 28 November 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (6) , 1225-1230
Development of the AAcQLI : A New Instrument for Assessing Quality of Life in Children With Alopecia Areata
Background: Alopecia areata (AA) is a chronic inflammatory disease characterized by non‐scarring hair loss, which can markedly affect the quality of life (QoL) of children. The absence of disease‐specific instruments to measure this impact motivated the development of the Alopecia Areata Children's Quality of Life Index (AAcQLI). Methods: This study aims to develop and validate a disease‐specific instrument to assess QoL in children with AA, addressing emotional, social, and functional domains. The AAcQLI was developed through a review of existing instruments, refined by an expert committee, and tested in a pilot sample. Its psychometric properties were evaluated by examining content and construct validity, while reliability was assessed through test–retest and internal consistency using Cronbach's α coefficient. Results: The study sample comprised 20 children, with a median age of 9.5 years (interquartile range [IQR] = 7.5–13). The AAcQLI demonstrated good internal consistency (Cronbach's α = 0.86) and excellent content validity (Content Validity Index = 1.0). Convergent validity indicated fair agreement with the Children's Dermatology Life Quality Index (CDLQI) ( k = 0.24) and slight agreement, as measured by the Severity of Alopecia (SALT) ( k = 0.08). Conclusion: The AAcQLI is a promising tool for assessing quality of life in children with AA. Further studies with larger and more diverse populations are warranted to refine its measurement properties and strengthen its clinical applicability in evaluating the psychosocial impact of the disease.
- 18 April 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-3
Frequency of sleep disturbances and signs of attention deficit and hyperactivity disorder in schoolchildren with atopic dermatitis
- 18 April 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-3
Frequency of sleep disturbances and signs of attention deficit and hyperactivity disorder in schoolchildren with atopic dermatitis
- Open Access
- 29 May 2024
- Published by Georg Thieme Verlag KG in Sleep Science
- Vol. 18 (01) , e97-e103
Atopic Dermatitis, Sleep, and the COVID-19 Pandemic
Objective To investigate sleep disorders among children with atopic dermatitis (AD), before and during the coronavirus disease 2019 (COVID-19) pandemic. Materials and Methods The present longitudinal, prospective study included 26 patients with AD, and the Sleep Disturbance Scale for Children (SDSC) questionnaire and questions about sleep hygiene were used. The severity of AD was determined by the Patient-Oriented Eczema Measure (POEM). The first evaluation was conducted before the pandemic (in 2019) and the second, during the pandemic, from September to December 2020. Results Sleep disorder was present in 17 (65.38%) patients in the 1st evaluation, and in 11 (42.30%) in the 2nd (p = 0.04). In the 1st evaluation, disorders of initiating and maintaining sleep (DIMSs) were more frequent in patients with moderate-to-severe AD (83.33%). During the pandemic, 6 patients (23.07%) reported improvement in sleep quality. Conclusion Sleep quality was negatively influenced by the severity of AD. During the COVID-19 pandemic, there was improvement in sleep quality, despite the absence of changes in disease severity.
- 29 May 2024
- Published by Georg Thieme Verlag KG in Sleep Science
- Vol. 18 (01) , e97-e103
Open AccessAtopic Dermatitis, Sleep, and the COVID-19 Pandemic
Objective To investigate sleep disorders among children with atopic dermatitis (AD), before and during the coronavirus disease 2019 (COVID-19) pandemic. Materials and Methods The present longitudinal, prospective study included 26 patients with AD, and the Sleep Disturbance Scale for Children (SDSC) questionnaire and questions about sleep hygiene were used. The severity of AD was determined by the Patient-Oriented Eczema Measure (POEM). The first evaluation was conducted before the pandemic (in 2019) and the second, during the pandemic, from September to December 2020. Results Sleep disorder was present in 17 (65.38%) patients in the 1st evaluation, and in 11 (42.30%) in the 2nd (p = 0.04). In the 1st evaluation, disorders of initiating and maintaining sleep (DIMSs) were more frequent in patients with moderate-to-severe AD (83.33%). During the pandemic, 6 patients (23.07%) reported improvement in sleep quality. Conclusion Sleep quality was negatively influenced by the severity of AD. During the COVID-19 pandemic, there was improvement in sleep quality, despite the absence of changes in disease severity.
- 1 January 2021
- Published by GN1 Sistemas e Publicacoes Ltd. in Jornal Paranaense de Pediatria
- Vol. 22
QUANDO PARECE MAS NÃO É: PITIRÍASE ROSEA UM DIAGNÓSTICO DIFERENCIAL DE TINEA CORPORIS
- 1 January 2021
- Published by GN1 Sistemas e Publicacoes Ltd. in Jornal Paranaense de Pediatria
- Vol. 22
QUANDO PARECE MAS NÃO É: PITIRÍASE ROSEA UM DIAGNÓSTICO DIFERENCIAL DE TINEA CORPORIS